A review of current progress in triple-negative breast cancer therapy

A review of current progress in triple-negative breast cancer therapy

Triple-negative breast cancer (TNBC) is a particularly aggressive subtype known for its extremely high drug resistance, progression, poor prognosis, and lack of clear therapeutic targets. Researchers are aiming to advance TNBC treatment worldwide. In the past 2–3 years, more positive results have em...

Full description

Bibliographic Details
Main Authors: Shen Meiying, Pan Huawen, Chen Yuxia, Xu Yu Hang, Yang Weixiong, Wu Zhaojun
Format: Article
Language:English
Published: De Gruyter 2020-11-01
Series:Open Medicine
Subjects:
triple-negative breast cancer
parp inhibition
immunotherapy
adjuvant therapy
Online Access:https://doi.org/10.1515/med-2020-0138

Internet

https://doi.org/10.1515/med-2020-0138

Similar Items